Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
Article History
Accepted: 22 March 2022
First Online: 9 April 2022
Change Date: 15 August 2022
Change Type: Update
Change Details: Missing Open Access funding information has been added in the Funding Note.
Declarations
:
: TD declares grants from the Berlin Institute of Health and Canon Medical Systems and consulting fees from Eli Lilly and lecture fees from Novartis, MSD and Canon Medical Systems. KGH reports consulting fees from Calyx and AbbVie and lecture fees from Novartis, MSD and Pfizer; he is co-founder of BerlinFlame GmbH. RGL reports consulting fees by Calyx, CARE Arthritis and Image Analysis Group and lecture fees from CARE Arthritis.
: This article does not contain any studies with human or animal subjects performed by any of the authors.